User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 01:37, 4 February 2025 Homo sapiens:Alzheimer's disease (Economize layout)
- 01:32, 4 February 2025 Homo sapiens:Alzheimer's disease (Economize layout)
- 01:29, 4 February 2025 Homo sapiens:Alzheimer's disease (Economize layout)
- 01:25, 4 February 2025 Homo sapiens:Alzheimer's disease (Economize layout)
- 13:09, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Modified description)
- 13:08, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Ontology Term : 'drug pathway' added !)
- 13:07, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Widen nodes)
- 13:07, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Widen node)
- 13:06, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Widen node)
- 13:06, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Remove anchor)
- 13:05, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Connect downstream effects)
- 13:01, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Add literature reference)
- 13:00, 3 February 2025 Homo sapiens:NSAIDs mechanism of action (Add more nodes, interactions, labels)
- 03:08, 3 February 2025 N Homo sapiens:NSAIDs mechanism of action (New pathway)
- 01:04, 3 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Shrink last nucleus)
- 01:03, 3 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Economize layout)
- 22:47, 2 February 2025 Homo sapiens:Mevalonate arm of cholesterol biosynthesis pathway with inhibitors (Ontology Term : 'statin drug pathway' added !)
- 22:16, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Refine graphical X placement)
- 22:01, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Remove a rolling indicator due to curved line rendering bug)
- 22:00, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Mitigate graphical bug due to PathVisio / Kaavio discrepancy)
- 21:59, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Mitigate graphical bug due to PathVisio / Kaavio discrepancy)
- 21:58, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Add, refine rolling indicator)
- 21:50, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Ontology Term : 'ulcerative colitis' added !)
- 21:49, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Ontology Term : 'Crohn's disease' added !)
- 21:47, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Ontology Term : 'irritable bowel syndrome' added !)
- 21:47, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Ontology Term : 'lymphocyte' added !)
- 21:46, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Ontology Term : 'endothelial cell of vascular tree' added !)
- 21:46, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Modified description)
- 21:43, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Add literature reference)
- 21:41, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Abut endothelial cells)
- 21:39, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Add familiar terms)
- 21:35, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Modified description)
- 21:32, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Label tissues)
- 21:28, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Adjust position of cell type label, nucleus)
- 21:25, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Fix connection)
- 21:24, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Refine color, add interaction)
- 21:22, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Refine color)
- 21:20, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Add color)
- 21:06, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Add process phases, label cell types)
- 13:28, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Refine graphics)
- 13:27, 2 February 2025 Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (Upgrade to complexes, add interactions)
- 13:13, 2 February 2025 N Homo sapiens:Vedolizumab therapy for inflammatory bowel disease (New pathway)
- 03:18, 2 February 2025 Homo sapiens:Arrhythmogenic right ventricular cardiomyopathy (Ontology Term : 'cardiac muscle cell' added !)
- 03:13, 2 February 2025 Canis familiaris:Hypertrophy model (Modified title) (top)
- 03:13, 2 February 2025 Homo sapiens:HIF1A and PPARG in hypertrophic cardiomyopathy (Modified title)
- 02:19, 2 February 2025 Homo sapiens:Acute viral myocarditis (Refine label layout)
- 02:17, 2 February 2025 Homo sapiens:Acute viral myocarditis (Economize layout)
- 01:33, 2 February 2025 Homo sapiens:Affected pathways in Duchenne muscular dystrophy (Refine node placement)
- 01:32, 2 February 2025 Homo sapiens:Affected pathways in Duchenne muscular dystrophy (Refine node placement)
- 01:30, 2 February 2025 Homo sapiens:Affected pathways in Duchenne muscular dystrophy (Refine node placement)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
